These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28681154)

  • 1. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.
    Toriola AT; Ziegler M; Li Y; Pollak M; Stolzenberg-Solomon R
    Ann Surg Oncol; 2017 Oct; 24(11):3212-3219. PubMed ID: 28681154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
    Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
    Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
    Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
    Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer.
    Evans JD; Eggo MC; Donovan IA; Bramhall SR; Neoptolemos JP
    Int J Pancreatol; 1997 Oct; 22(2):95-100. PubMed ID: 9387030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer.
    Harman SM; Metter EJ; Blackman MR; Landis PK; Carter HB;
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4258-65. PubMed ID: 11095464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.
    Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between risk of biliary tract cancer and circulating IGF (Insulin-like Growth Factor) -I, IGF-II or IGFBP-3 (IGF-binding Protein-3): A nested case-control study in a large scale cohort study in Japan.
    Yagyu K; Kikuchi S; Lin Y; Ishibashi T; Obata Y; Kurosawa M; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():63-7. PubMed ID: 20553084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer.
    Winter DL; Hanlon AL; Raysor SL; Watkins-Bruner D; Pinover WH; Hanks GE; Tricoli JV
    Urology; 2001 Oct; 58(4):614-8. PubMed ID: 11597555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population.
    Martin RM; Gunnell D; Whitley E; Nicolaides A; Griffin M; Georgiou N; Davey Smith G; Ebrahim S; Holly JM
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1331-8. PubMed ID: 18211967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
    Fuchs CS; Goldberg RM; Sargent DJ; Meyerhardt JA; Wolpin BM; Green EM; Pitot HC; Pollak M
    Clin Cancer Res; 2008 Dec; 14(24):8263-9. PubMed ID: 19073970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor.
    McCaffery I; Tudor Y; Deng H; Tang R; Suzuki S; Badola S; Kindler HL; Fuchs CS; Loh E; Patterson SD; Chen L; Gansert JL
    Clin Cancer Res; 2013 Aug; 19(15):4282-9. PubMed ID: 23741071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults.
    Johnsen SP; Sørensen HT; Thomsen JL; Grønbaek H; Flyvbjerg A; Engberg M; Lauritzen T
    Eur J Epidemiol; 2004; 19(1):41-7. PubMed ID: 15012021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
    Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
    Acerini CL; Clayton KL; Hintz R; Baker B; Watts A; Holly JM; Dunger DB
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
    Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke.
    Johnsen SP; Hundborg HH; Sørensen HT; Orskov H; Tjønneland A; Overvad K; Jørgensen JO
    J Clin Endocrinol Metab; 2005 Nov; 90(11):5937-41. PubMed ID: 16131586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.